1. The synthesis, release, and binding of substance P
Brendan A. Hilliard, Robert Vink, and Mary F. Barbe
2. Distribution of substance P receptors in mammals
Honoo Satake, Akira Shiraishi, and Tsuyoshi Kawada
3. Substance P in nonmammalian biology: Evolutionarily conserved tachykinin signaling
Dick R. Nassel
4. Methodological foundations of substance P detection
Nuray Erin
5. Substance P receptor antagonists
Francisco D. Rodrıguez and Rafael Covenas
6. Substance P in the cardiovascular system
Magdalena Chottova Dvorakova and Shashank Pandey
7. Substance P in lower urinary tract function and dysfunction
Mitsuharu Yoshiyama
8. Role of the substance P in learning and memory
Natalia Favila and Paul G. Overton
9. Substance P in nausea and vomiting
Paul L.R. Andrews, John A. Rudd, and Gareth J. Sanger
10. Substance P in the central control of respiration
Nicholas J. Burgraff and Jan-Marino Ramirez
11. Substance P in bone metabolism
Tanja Niedermair and Susanne Grassel
12. Life without substance P: The naked mole rat
Aishi Zhao, Jiwon Lee, Weronika Gryszkiewicz, and Thomas J. Park
13. Substance P in inflammation
Sophie E. Sipprell and Ian Marriott
14. Substance P in oxidative stress
Seyed Isaac Hashemy and Safieh Ebrahimi
15. Substance P in pain
Robert Vink
16. Substance P in cancer
Miguel Munoz, Marisa Rosso, Riffat Mehboob, and Francisco Esteban
17. Substance P in cardiac dysfunction
Scott P. Levick and Alexander Widiapradja
18. Substance P in neurotrauma
Rebecca George, Justin Krieg, and Frances Corrigan
19. Substance P in stroke
Annabel Sorby-Adams
20. Substance P in Alzheimer’s and Parkinson’s disease
Severini Cinzia
21. Substance P receptor antagonists for major depressive disorder
Nadia M.J. Rupniak and Mark S. Kramer
22 From a putative antidepressant to a validated mouse model of ADHD via NK1 receptors
S.C. Stanford
23. Substance P in stress and anxiety
Karl Ebner and Nicolas Singewald
24. Substance P-neurokinin 1 receptor pathway in musculoskeletal disorders
Brendan A. Hilliard and Mary F. Barbe
25. Substance P and sudden infant death syndrome (SIDS)
F. Bright, Robert Vink, and R.W. Byard
26. Immunobiology and pharmacology of neuropeptide substance P
Ehsan Aslam, Asina Gijasi, Caroline Perner, Rob van Wijk, Anne-Grete Martson, Gerard J.P. van Westen, Ilze Bot, Laura H. Heitman, and Alireza Mashaghi
27. Substance P in viral diseases—Especially coronavirus disease
Riffat Mehboob, Mariam Hashim, and Miguel Munoz
28. Substance P: Perspectives and future directions
Robert Vink